GlassScriptPhysician profile
Robert A Cirino
NPI 1194766204
$485.39
in general payments reported to CMS, 2019-2025
11 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $135 · 2023: $110 · 2024: $126 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $150.11 | 2022-2025 | Eliquis |
| Abbvie INC. | $93.15 | 2023-2024 | Vraylar |
| Glaxosmithkline, LLC. | $58.91 | 2024-2025 | Shingrix, Arexvy |
| Supernus Pharmaceuticals, INC. | $48.19 | 2022 | |
| Amgen INC. | $41.71 | 2025 | Evenity, Prolia |
| Novartis Pharmaceuticals Corporation | $20.00 | 2024 | |
| Astellas Pharma US INC | $18.16 | 2024 | Veozah |
| Vbi Vaccine (Delaware) INC. | $16.80 | 2022 | |
| Novo Nordisk INC | $13.54 | 2022 | |
| Echosens North America, INC. | $13.00 | 2025 | Fibroscan |
| Pfizer INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cirino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.